FREE

Generics in Mexico

Generics in Mexico

Summary

Generics in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Mexico generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The market value is evaluated at ex-factory prices.
Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.
Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.
Please note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.
All currency conversions were calculated at constant average annual 2016 exchange rates.

The Mexican generics market had total revenues of $5,430.1m in 2016, representing a compound annual growth rate (CAGR) of 14.3% between 2012 and 2016.

Market consumption volume increased with a CAGR of 6% between 2012 and 2016, to reach a total of 88.4% of total pharma volume in 2016.

Fast approval and deregulation will mean that the Mexican generics market continues to thrive.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Mexico
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico generics market with five year forecasts by both value and volume

Reasons to buy

- What was the size of the Mexico generics market by value in 2016?
- What will be the size of the Mexico generics market in 2021?
- What factors are affecting the strength of competition in the Mexico generics market?
- How has the market performed over the last five years?
- How large is Mexico’s generics market in relation to its regional counterparts?